PaperTrue

     恭喜清华大学电子工程系余佳东团队喜中ADVANCED MATERIALS(IF:25.8),购买服务为:优质润色 点击查看更多发表案例
以下是对 INT J PHARMACEUT 杂志介绍 收藏
缩写名/全名
INT J PHARMACEUT
INTERNATIONAL JOURNAL OF PHARMACEUTICS
ISSN号 0378-5173
研究方向 医学-药学
影响因子 2015:3.994, 2016:3.649, 2017:3.862, 2018:4.213, 2019:4.845,
出版国家 NETHERLANDS
出版周期 Biweekly
年文章数 879
出版年份 1978
是否OA No
审稿周期(仅供参考) 平均2.5个月
来源Elsevier官网:平均4.8周
录用比例 约75%
投稿链接 http://ees.elsevier.com/ijp/
投稿官网 http://www.elsevier.com/wps/find/journaldescription.cws_home/505513/description
h-index 190
CiteScore
CiteScoreSJRSNIPCiteScore排名
4.351.1351.230
学科分区排名
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmaceutical Science
Q115 / 164

PubMed Central (PMC)链接 http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0378-5173%5BISSN%5D
中科院SCI期刊分区
( 2018年新版本)
大类学科小类学科Top期刊综述期刊
医学 1区2区2区
PHARMACOLOGY & PHARMACY
药学
2区3区2区
中科院SCI期刊分区
( 2020年新版本)
大类学科小类学科Top期刊综述期刊
医学 4区2区1区
PHARMACOLOGY & PHARMACY
药学
4区4区2区
  • 该杂志上中国学者近期发表的论文
  • 同领域相关期刊
中国学者近期发表的论文
1.DNA scaffold nanoparticles coated with HPMC/EC for oral delivery

Author: Mirza Muhammad Faran Ashraf Baig, Muhammad Naveed, Muhammad Abbas, Wen Chunxia, Sana Ullah, Muhammad Hasnat, Asam Shad, Sohail Muhammad, Ghulam Jilany Khan, Muhammad Tayyab Ansari
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, Vol., , DOI:10.1016/j.ijpharm.2019.03.054
    DOI
2.Spontaneously formed porous structure and M1 polarization effect of Fe3O4 nanoparticles for enhanced antitumor therapy

Author: Ting Gong, Xu Song, Liuqing Yang, Tijia Chen, Ting Zhao, Tao Zheng, Xun Sun, Tao Gong, Zhirong Zhang
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, Vol.559, 329-340, DOI:10.1016/j.ijpharm.2019.01.048
    DOI
3.Pluronic F127-based micelles for tumor-targeted bufalin delivery

Author: Haijun Wang, Gareth R. Williams, Jianrong Wu, Junzi Wu, Shiwei Niu, Xiaotian Xie, Shude Li, Li-Min Zhu
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, Vol.559, 289-298, DOI:10.1016/j.ijpharm.2019.01.049
    DOI
4.Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy

Author: Huangliang Zheng, Jiaqi Li, Mengjing Wang, Xiang Luo, Qiujun Qiu, Ling Hu, Cong LI, Yanzhi Song, Yihui Deng
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, Vol.558, 187-200, DOI:10.1016/j.ijpharm.2019.01.005
    DOI
5.Preparation of pH-responsive DOX-loaded chitosan nanoparticles using supercritical assisted atomization with an enhanced mixer

Author: Hu-Hong Peng, Dong-Xiao Hong, Yi-Xin Guan, Shan-Jing Yao
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, Vol.558, 82-90, DOI:10.1016/j.ijpharm.2018.12.077
    DOI
6.A thermo-responsive and self-healing liposome-in-hydrogel system as an antitubercular drug carrier for localized bone tuberculosis therapy

Author: Peng Liu, Binbin Guo, Shengfeng Wang, Jinsong Ding, Wenhu Zhou
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, Vol.558, 101-109, DOI:10.1016/j.ijpharm.2018.12.083
    DOI
7.Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors

Author: Parikshit Banerjee, Tianjiao Geng, Arpan Mahanty, Tiantian Li, Li Zong, Bo Wang
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2019, Vol.557, 374-389, DOI:10.1016/j.ijpharm.2018.12.051
    DOI
8.Effective co-encapsulation of doxorubicin and irinotecan for synergistic therapy using liposomes prepared with triethylammonium sucrose octasulfate as drug trapping agent

Author: Jieru Liu, Dongxu Chi, Siyan Pan, Liwen Zhao, Xue Wang, Dun Wang, Yongjun Wang
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, Vol.557, 264-272, DOI:10.1016/j.ijpharm.2018.12.072
    DOI
9.Floating molecularly imprinted polymers based on liquid crystalline and polyhedral oligomeric silsesquioxanes for capecitabine sustained release

Author: Chun-E Mo, Mei-Hong Chai, Li-Ping Zhang, Rui-Xue Ran, Yan-Ping Huang, Zhao-Sheng Liu
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, Vol.557, 293-303, DOI:10.1016/j.ijpharm.2018.12.070
    DOI
10.Drug-delivering-drug approach-based codelivery of paclitaxel and disulfiram for treating multidrug-resistant cancer

Author: Imran Shair Mohammad, Chao Teng, Birendra Chaurasiya, Lifang Yin, Chunyong Wu, Wei He
Journal: INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, Vol.557, 304-313, DOI:10.1016/j.ijpharm.2018.12.067
    DOI
同类著名期刊名称 h-index CiteScore
PHARMACOLOGICAL REVIEWS21018.73
TRENDS IN PHARMACOLOGICAL SCIENCES2019.98
ADVANCED DRUG DELIVERY REVIEWS27813.90
DRUG RESISTANCE UPDATES10013.15
PHARMACOLOGY & THERAPEUTICS18010.16
MEDICINAL RESEARCH REVIEWS1198.83
BRITISH JOURNAL OF PHARMACOLOGY1906.12
DRUG DISCOVERY TODAY1577.08
CLINICAL PHARMACOLOGY & THERAPEUTICS1734.47
PHARMACOLOGICAL RESEARCH1185.27
中科院JCR同大类学科的热搜期刊 浏览次数
MEDICINE292806
CANCER RESEARCH164419
Molecular Medicine Reports163021
International Journal of Nanomedicine162982
CANCER LETTERS158004
JOURNAL OF ETHNOPHARMACOLOGY140003
BIOMEDICINE & PHARMACOTHERAPY138354
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY134545
Theranostics133954
International Journal of Environmental Research and Public Health132137